🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

The Ensign Group, Inc. ENSG R2K

Healthcare · Medical Care Facilities · United States
https://ensigngroup.net

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

READ MORE ›
$167.65
+14.01% 1Y

Market & Price

Market Cap
$9.80B
Current Price
$167.65
High / Low (52W)
$215.76 / $136.22
Beta
0.73

Valuation

Stock P/E
27.30
Industry PE
23.65
Forward P/E
20.13
PEG Ratio
1.51
Book Value
$40.84
Price to Book
4.10
P/S
1.86
EV/EBITDA
20.43
Dividend Yield
0.16%

Profitability & Returns

ROCE
10.15%
ROE
16.92%
ROA
5.41%
Profit Margin
6.89%
Op Margin
8.99%
EPS (Latest Qtr)
$1.67
EPS (TTM)
$6.14

Balance Sheet & Liquidity

Debt/Equity
0.95
Quick Ratio
1.48
Current Ratio
1.56
Debt
$2.24B
Total Assets
$5.46B
Current Assets
$1.27B
Working Capital
$377.96M

Ownership

Promoter Holding
3.52%
Chg in Prom Hold
-0.01%
FII / Inst Holding
94.75%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
$11.37B
Total Revenue (TTM)
$5.27B
EBITDA
$556.63M
Free Cash Flow
$291.29M
Operating Cash Flow
$592.20M
Shares Outstanding
58.45M
Gross Margin
16.43%
Payout Ratio
4.15%

Growth (CAGR)

Revenue 5Y
18.68%
Profit 5Y
15.25%
Revenue (YoY)
18.40%
Earnings (YoY)
21.90%

PROS

  • Compounding revenue at 18.7% over 5 years.
  • Profit CAGR of 15.3% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 ENSG The Ensign Group, Inc. R2K 167.65 27.30 $9.80B 0.16% 10.15% 16.92% 18.68% 15.25%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
⚙Ad space

Quarterly Results

Figures in USD.

Metric Jun 2013Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -------------471.59M492.13M496.39M514.36M471.31M492.92M512.11M589.61M584.70M599.25M627.25M638.54M668.53M713.45M732.49M770.00M886.84M921.35M940.79M1.01B1.03B1.08B1.17B1.23B1.30B1.36B1.39B
Cost of Revenue -----------------------------------984.92M1.03B1.11B1.14B1.16B
Gross Profit -----------------------------------188.12M198.79M190.22M222.32M227.86M
Operating Expenses -----------------------------------86.74M94.89M94.00M98.51M103.01M
Operating Income 23.29M20.29M24.35M13.64M15.29M25.17M21.98M21.59M16.32M19.81M20.04M7.55M22.03M25.56M32.98M31.77M29.29M29.95M28.74M30.80M56.79M55.43M55.07M63.68M64.85M66.32M69.11M78.23M74.29M74.88M77.87M79.79M82.22M85.97M89.34M101.37M103.90M96.22M123.81M124.85M
EBITDA -----------------------------------132.81M140.17M135.20M159.76M159.31M
Interest Expense -----------------------------------2.04M2.02M1.97M1.96M1.93M
Pretax Income -----------------------------------106.58M112.36M106.60M130.08M128.57M
Tax Provision -----------------------------------26.23M27.89M22.69M34.55M28.82M
Net Income 12.37M10.46M13.53M2.01M8.91M15.17M13.19M13.47M9.17M11.33M11.15M2.84M12.22M14.21M23.13M22.01M20.86M27.37M28.61M27.16M40.85M40.25M43.06M49.21M49.42M47.28M50.34M57.69M56.18M59.85M63.99M63.86M68.83M71.01M78.44M80.28M84.40M83.84M95.45M99.67M
Diluted EPS 0.550.470.600.090.380.310.250.250.180.220.210.050.230.270.430.410.380.490.510.480.730.730.770.860.870.830.891.010.991.051.121.111.191.221.341.371.441.421.611.67

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -------1.65B1.60B1.75B2.04B2.39B-3.03B3.73B4.26B5.06B
Cost of Revenue -------------2.51B3.14B3.59B4.26B
Gross Profit -------------517.99M590.76M667.59M799.45M
Operating Expenses -------------221.16M335.39M309.28M374.15M
Operating Income 58.94M75.65M90.70M78.27M57.94M72.92M93.08M91.85M43.19M84.91M129.18M223.16M-296.82M255.37M358.30M425.31M
EBITDA -------------360.38M353.24M478.52M567.94M
Interest Expense -------------8.93M8.09M8.29M7.99M
Pretax Income -------------289.09M272.76M386.09M455.62M
Tax Provision -------------64.44M62.91M87.64M111.36M
Net Income 32.49M40.53M47.67M40.59M24.04M35.95M55.43M49.99M40.48M92.36M110.53M170.48M-224.68M209.40M297.97M343.97M
Diluted EPS 1.551.922.211.850.540.781.060.960.771.701.973.06-3.953.655.125.84

Compounded Sales Growth

5 Years:18.68%
1 Year:18.40%

Compounded Profit Growth

5 Years:15.25%
1 Year:21.90%

Stock Price Performance

1 Year:+14.01%
6 Months:-10.54%
3 Months:-21.70%
1 Month:-10.06%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Sep 2012Dec 2012Dec 2013Dec 2014Dec 2015Jun 2016Dec 2016Dec 2017Dec 2018Jan 2019Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --479.89M596.34M-690.86M760.32M493.92M747.76M-1.00B1.10B1.18B2.20B2.36B2.55B-3.45B4.18B4.67B5.46B
Current Assets -----------------781.12M1.05B1.16B1.27B
Cash & Equivalents 41.33M38.85M72.09M29.58M40.69M40.69M65.75M50.41M41.57M41.57M57.71M42.34M31.04M-59.17M236.56M-316.27M509.63M464.60M503.88M
Inventory ---------------------
Receivables -----------------408.43M485.04M569.90M636.99M
Total Liabilities -----362.98M403.06M236.11M320.77M-540.53M602.37M579.62M1.59B1.71B1.73B-2.20B2.68B2.83B3.23B
Current Liabilities --83.37M100.39M-121.35M112.46M130.43M179.87M-211.93M225.82M269.23M-343.17M562.40M-582.07M734.75M743.43M894.35M
Long Term Debt --139.45M181.56M-200.50M251.90M68.28M99.05M-275.49M302.99M233.13M----149.27M145.50M141.59M137.53M
Total Debt -----------------1.57B1.87B1.97B2.21B
Total Equity 156.02M187.56M228.20M277.49M-326.47M356.10M258.85M427.32M-456.45M492.40M590.93M-654.20M818.08M-1.25B1.49B1.84B2.23B
Shares Outstanding -----------------59.03M59.99M60.84M61.65M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 46.27M60.50M72.69M82.05M37.42M84.88M33.37M73.89M79.54M210.30M192.22M373.35M-272.51M376.67M347.19M564.27M
Investing Cash Flow -80.47M-57.19M-156.05M-84.50M-65.23M-172.85M-168.54M-210.64M-113.18M-151.21M-247.01M-58.67M--186.18M-182.70M-390.05M-513.18M
Financing Cash Flow 31.73M29.92M40.86M13.55M52.88M72.62M126.33M152.88M18.27M-70.34M82.88M-137.30M--32.26M-612.00K-2.16M-11.81M
Capital Expenditure -21.88M-28.72M-40.77M-38.85M-29.76M-53.69M-60.02M-65.70M-54.08M-50.89M-71.54M---87.55M-106.18M-158.24M-193.56M
Free Cash Flow 24.39M31.78M31.91M43.20M7.67M31.19M-26.65M8.19M25.46M159.41M120.68M--184.97M270.49M188.95M370.71M
Net Change in Cash -------------54.07M193.36M-45.03M39.28M
Share Buybacks -00174.00K00030.00M7.29M06.41M25.00M10.12M29.88M0020.00M
Dividends Paid 3.71M4.15M4.64M6.60M4.32M6.30M7.49M8.17M8.72M9.42M10.19M10.83M11.55M12.17M12.89M13.67M14.41M

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------------17.1%15.8%15.7%15.8%
Operating Margin % -------5.6%2.7%4.8%6.3%9.3%-9.8%6.8%8.4%8.4%
Net Margin % -------3.0%2.5%5.3%5.4%7.1%-7.4%5.6%7.0%6.8%
ROE % 17.3%17.8%17.2%12.4%6.8%13.9%13.0%11.0%8.2%15.6%16.9%20.8%-18.0%14.0%16.2%15.4%
ROCE % -19.1%18.3%13.7%8.9%20.1%16.4%11.6%4.9%9.3%6.4%11.3%-10.3%7.4%9.1%9.3%

Shareholding Pattern

Insiders
3.52%
Institutions
94.75%
Public Float
98.21%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 12.60% 7.36M $1.23B
2 BAILLIE GIFFORD & CO 8.26% 4.83M $809.11M
3 Vanguard Portfolio Management LLC 5.34% 3.12M $523.12M
4 Vanguard Capital Management LLC 4.44% 2.59M $434.70M
5 FMR, LLC 3.93% 2.30M $385.00M
6 State Street Corporation 3.53% 2.06M $345.84M
7 Wasatch Advisors LP 3.52% 2.06M $345.02M
8 Geode Capital Management, LLC 2.89% 1.69M $282.87M
9 Capital Research Global Investors 2.40% 1.40M $235.06M
10 Price (T.Rowe) Associates Inc 2.24% 1.31M $219.33M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ENSG

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space